Home / Publications / Santen ends Neurim-style SPCs

Santen ends Neurim-style SPCs

14/07/2020

The wording of Article 3(d) of the SPC Regulation requires that the SPC application must rely on “the first authorisation to place the product on the market as a medicinal product”. This suggests that a marketing authorisation granted for a new indication...

Read more

Authors

Portrait ofRobert Stephen
Robert Stephen
Partner
London